Our abGCN captures a distinct property of the CD276 high-expressing (CD276high) malignant glioma cell population (GSCs) in each slide in the form of graphs that are representative of the respective biopsy/case and based on global information from the WSI. Here, CD276 is linked to malignant glioma.